Blood Pressure-Lowering Peptides Hidden in Your Food | Research

The takeaway

Peptides naturally present in milk, meat, fish, soy, and other foods can lower blood pressure by blocking the same enzyme system that pharmaceutical ACE inhibitors target.

3 blood pressure-lowering mechanisms
Food-derived peptides target blood pressure through renin inhibition, ACE inhibition, and angiotensin II receptor blocking — covering the entire RAS pathway

What the researchers found

Food-derived peptides from diverse sources — milk, meat, fish, eggs, soy, rice, wheat, mushrooms, and pumpkins — can lower blood pressure through multiple mechanisms targeting the renin-angiotensin system (RAS). These peptides inhibit both renin and angiotensin-converting enzyme (ACE), the two key enzymes that raise blood pressure.

Beyond enzyme inhibition, food-derived ACE inhibitory peptides also enhance nitric oxide production in blood vessel walls, promoting vasodilation (blood vessel relaxation). Additionally, they can block the interaction between angiotensin II and its receptor, providing a third mechanism for blood pressure reduction.

The review surveys the breadth of food sources containing antihypertensive peptides and their various applications for managing cardiovascular disease.

Why it matters

Hypertension affects over a billion people worldwide and is the leading modifiable risk factor for cardiovascular disease. While pharmaceutical ACE inhibitors are highly effective, food-derived peptides offer a potential complementary approach with fewer side effects. Understanding which foods naturally contain blood pressure-lowering peptides could inform dietary recommendations and functional food development for people with mild hypertension or those seeking to prevent it.

The numbers in context

Multiple food sources surveyed · 3 mechanisms identified: renin inhibition, ACE inhibition, angiotensin II receptor blocking · Nitric oxide enhancement pathway documented

How the study worked

This is a narrative review surveying published literature on food-derived antihypertensive peptides. It covers peptide sources (dairy, animal, plant, and other food proteins), mechanisms of action (renin inhibition, ACE inhibition, angiotensin II receptor blocking, nitric oxide enhancement), and applications for cardiovascular disease management.

Who was studied

Review of research on food-derived antihypertensive peptides (no direct study population)

What this study cannot tell us

As a narrative review, it synthesizes existing literature without conducting meta-analysis or quantifying effect sizes. Most food-derived peptide research involves in vitro ACE inhibition assays or small clinical studies — large-scale human trials are limited. The blood pressure-lowering effects of food peptides are generally modest compared to pharmaceutical ACE inhibitors.

How to read the evidence

This is a preliminary-grade narrative review that surveys the field without systematic methodology or meta-analysis. Most underlying evidence comes from in vitro studies and small clinical trials, with limited large-scale human data.

When this study was published

Published in 2022, this is a recent survey of the food-derived antihypertensive peptide landscape that captures current research trends and applications.

The bigger picture

Food-derived bioactive peptides represent a growing area at the intersection of nutrition science and pharmacology. Several peptide-containing products — particularly fermented milk products like lactotripeptides (IPP and VPP) — have been commercialized as functional foods for blood pressure management in Japan and Europe. As regulatory frameworks for health claims evolve, food-derived peptides may increasingly bridge the gap between dietary intervention and pharmaceutical treatment.

Questions still open

How do the blood pressure-lowering effects of food-derived peptides compare quantitatively to pharmaceutical ACE inhibitors?
Do these peptides survive digestion intact enough to reach the bloodstream and exert effects?
Could concentrated food-derived peptide supplements replace low-dose blood pressure medications in mild hypertension?

Common questions

Can eating certain foods actually lower blood pressure?

Yes, to a modest degree. Foods like fermented milk, fish, soy, and certain grains contain peptides that inhibit ACE — the same enzyme targeted by blood pressure drugs like lisinopril. The effect is milder than medications but can complement a healthy diet and exercise program for blood pressure management.

How are food peptides different from ACE inhibitor drugs?

Food-derived peptides target the same enzyme system but are much less potent than pharmaceutical ACE inhibitors. They're released during digestion of food proteins and have shorter-lasting effects. However, they typically don't cause the side effects associated with drugs (like chronic cough), making them interesting as dietary supplements or functional foods.

Read the original research

Current Trends and Applications of Food-derived Antihypertensive Peptides for the Management of Cardiovascular Disease.

Protein and peptide letters, 29(5), 408-428

View on PubMed ↗Publisher’s paper ↗

Citation

Shukla, Pratik; Chopada, Keval; Sakure, Amar; Hati, Subrota. (2022). Current Trends and Applications of Food-derived Antihypertensive Peptides for the Management of Cardiovascular Disease.. Protein and peptide letters, 29(5), 408-428. https://doi.org/10.2174/0929866529666220106100225